Vital Farms rose 9.2% after earnings, with third-quarter revenue up 10% sequentially and adjusted EBITDA returning to a $1.5 million profit from a $26.6 million loss in Q2. But the company cut its full-year sales outlook to about $730 million, citing a weaker-than-expected holiday build, later distribution gains and no assumed recovery in conventional egg prices.
Vital Farms reported results in line with the recent challenges detailed last quarter, with the stock essentially unchanged post-earnings as investors weighed a 10.1% decline in net sales amid ongoing supply oversupply and price gap issues. Despite operational adjustments, margin compression and revenue decline kept the market response muted.
Vital Farms reported a record net revenue of $198.9 million in Q3 2025, a 37.2% increase year-over-year, alongside a substantial 81.3% rise in adjusted EBITDA, signaling robust operational efficiency and market demand.